Roivant Sciences' (ROIV) Dermavant Announces FDA Approval of VTAMA Cream
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| DexCom, Inc. (NASDAQ: DXCM) | Delayed: 78.52 +0.20 (0.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $78.32 | 52 Week High | $96.38 | |||
| Open | $78.68 | 52 Week Low | $47.92 | |||
| Day High | $79.51 | P/E | N/A | |||
| Day Low | $78.15 | EPS | $-0.42 | |||
| Volume | 2,813,483 | |||||
| (NASDAQ: ROIV) | Delayed: 36.45 -1 (2.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $37.45 | 52 Week High | $ | |||
| Open | $37.18 | 52 Week Low | $ | |||
| Day High | $37.42 | P/E | N/A | |||
| Day Low | $36.40 | EPS | $ | |||
| Volume | 5,484,063 | |||||
